Search clinical trials for: atenolol (beta blocker) and hydrochlorothiazide (diuretic)

Total 1413 results

Idorsia Pharmaceuticals Ltd.

Terminated

Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441

Healthy Subjects

France
University of Florida
GlaxoSmithKline

Completed

Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure

Hypertension

United States
Centre Hospitalier Universitaire Vaudois

Completed

Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension

Hypertension

Switzerland
Eli Lilly and Company

Completed

A Study in People With Mild Hypertension

Mild Hypertension

Sweden
Boryung Pharmaceutical Co., Ltd

Completed

Fimasartan in the Senior Subjects (FITNESS)

The Elderly (≥ 70 Years) With Essential Hypertension

Korea, Republic of
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Hydrochlorothiazide

Obesity, Morbid

Norway
West China Hospital

Completed

Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

Hypertension | Renal Insufficiency

China
Uppsala University
Karolinska Institutet; Oslo University Hospital; Göteborg University; New York... and other collaborators

Terminated

Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT (MINOCA-BAT)

Myocardial Infarction With Non-obstructive Coronary Arteries

Norway, Sweden, Australia, New Zealand, Spain
Vanderbilt University Medical Center

Completed

Aldosterone and the Metabolic Syndrome

Glucose Metabolism Disorders | Metabolic Diseases | Diabetes Mellitus | Endocrine System Diseases

United States
AstraZeneca

Completed

Candesartan Effect in Second Stage Arterial Hypertension (CAESAR)

Stage II Hypertension

Korea, Republic of
Daiichi Sankyo Co., Ltd.

Completed

Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension

Hypertension

Japan
Daiichi Sankyo, Inc.

Completed

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

Hypertension | Metabolic Syndrome | Insulin Resistance

United States
Korea University

Unknown

Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding

Cirrhosis | Variceal Bleeding

Korea, Republic of
AstraZeneca

Completed

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo

Hypertension

Russian Federation, Latvia, Romania, Slovakia, Belgium, Malta
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension

Hypertension

China
Second Affiliated Hospital, School of Medicine,...
National Clinical Research Center, Southern Medical University; Ningbo Yinzhou...

Completed

Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension

Hypertension

China
Seoul National University Hospital

Completed

Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men

Nocturia

Korea, Republic of
University of Missouri-Columbia

Active, not recruiting

ENAC Blockade and Arterial Stiffness

Insulin Resistance | Overweight and Obesity

United States
Boehringer Ingelheim

Completed

Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects

Healthy
University Hospital Tuebingen

Terminated

Amiloride in Nephrotic Syndrome (AMILOR)

Edema | Nephrotic Syndrome | Sodium Retention

Germany
University of Southern Denmark
Odense University Hospital; Region of Southern Denmark

Completed

Increased Activity of ENaC in Proteinuric Kidney Transplant Recipients

Kidney Transplant; Complications

Denmark
University of Southern Denmark
Odense University Hospital; The Ministry of Science, Technology and Innovation... and other collaborators

Unknown

Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease

Hypertension | Diabetic Nephropathies

Denmark
Novartis Pharmaceuticals

Withdrawn

Aliskiren Study of Safety and Efficacy in Senior Hypertensives (ASSESS)

Hypertension
Novartis

Completed

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

Hypertension

United States
University of Maryland, Baltimore
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Terminated

Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes

Metabolic Syndrome

United States
Novartis

Completed

Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

Hypertension

Germany
Boehringer Ingelheim

Completed

Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers

Healthy

Japan
Daiichi Sankyo, Inc.

Completed

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Hypertension | Type 2 Diabetes

United States
Charite University, Berlin, Germany
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Recruiting

Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease (EXAMINE-CAD)

Coronary Artery Disease | Microvascular Angina | Vasospastic Angina | Coronary Microvascular Dysfunction | Vasospasm, Coronary | Prinzmetal Angina

Germany, Switzerland
Johannes Gutenberg University Mainz

Unknown

Telmisartan, Amlodipine and Flow Mediated Dilation (TEAMSTAprotect)

Hypertension

Germany
Boehringer Ingelheim

Terminated

Effect of Caldine® on Renal Function in Balanced Hypertension

Hypertension
Boston University

Withdrawn

Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT) (AIRCRAFT)

Atrial Fibrillation

United States
University of Western Ontario, Canada
Pfizer

Completed

STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia) (STITCH2)

Hypertension | Hypercholesterolemia

Canada
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Action to Control Cardiovascular Risk in Diabetes (ACCORD) (ACCORD)

Cardiovascular Diseases | Coronary Disease | Hypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Atherosclerosis | Hypercholesterolemia

United States, Canada
Instituto Ecuatoriano de Enfermedades Digestivas

Unknown

EUS-guided Combined Therapy Versus Beta Blocker Therapy in Primary Prophylaxis o GOV II and IGV I

Cirrhosis | GastroIntestinal Bleeding | Gastric Varix

Ecuador
The University of Texas Health Science Center at...

Withdrawn

High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure

Heart Failure

United States
Boston Children's Hospital
Cystic Fibrosis Foundation

Completed

Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis

Cystic Fibrosis

United States
LaborMed Pharma S.A.

Completed

A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM (AISHA)

Hypertension | Type 2 Diabetes Mellitus

Romania
Boehringer Ingelheim

Completed

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

Hypertension
McGill University
McGill University Health Centre/Research Institute of the McGill University... and other collaborators

Terminated

Withdrawal of Medication in Recovered DCM (WrecEF)

Dilated Cardiomyopathy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

Healthy

India
Nanjing Medical University

Unknown

Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery

Coronary Artery Disease | Acute Coronary Syndrome

China
Pfizer

Completed

A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension

Hypertension

Turkey
Ya-Wei Xu

Completed

Epidemic Profile of Left Ventricular Diastoic Dysfunction in the Community Elderly and Establishing Prediction Model: the Northern Shanghai Study (ELITISM)

Left Ventricular Diastoic Dysfunction Cohort Study
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension

Hypertension

United States, Canada, Germany, Russian Federation, France
University of Colorado, Denver
University of Aarhus

Completed

Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus

Nephrogenic Diabetes Insipidus

United States, Denmark
Organon and Co

Completed

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Hypertension | Type 2 Diabetes Mellitus
Pharmtechnology LLC
Altasciences Company, Inc.

Unknown

A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions

Bioequivalence

Canada
Hospital de Clinicas de Porto Alegre
Financiadora de Estudos e Projetos

Completed

Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension (PREVER)

Hypertension | Cardiovascular Disease

Brazil

Search clinical trials for: atenolol (beta blocker) and hydrochlorothiazide (diuretic)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations